Doctors Note Logo

Published on: 10/22/2026

Why Cannabis Use Changes Anaesthetic Doses

Regular cannabis use can raise the amount of anaesthetic needed, with studies showing frequent users often require significantly higher doses of propofol, sedatives, and opioids to reach and maintain surgical sedation. This happens because THC acts on cannabinoid receptors in the brain, builds cross-tolerance with other central nervous system depressants, and can alter liver enzyme activity that clears anaesthetic drugs, while also affecting heart rate, blood pressure, and airway reactivity. How much your dose changes depends on how often and how recently you used, the route (smoked vs edible), potency, and your other medications, so there are several important factors to consider below. Telling your anaesthetist about cannabis use is essential, because unreported use is linked to higher rates of intraoperative awareness, airway complications, and worse post-operative pain control. If you are preparing for surgery or noticing symptoms like chest tightness, nausea, dizziness, or unusual pain, a free, instant online symptom check can help you organize what you are experiencing and decide what to raise with your medical team next.

Last reviewed for medical accuracy: 10/22/2026

answer background

Concerned about your symptoms?

Explanation

Why Cannabis Use Changes Anaesthetic Doses

When patients use medical cannabis before anesthesia, anesthesiologists may need to adjust their drug dosing. Understanding these changes helps ensure safe, effective care. Below, we explore the key reasons cannabis alters anesthetic requirements, what research shows, and practical steps you can take.

1. How Cannabis Affects Drug Metabolism

Chronic cannabis use can speed up the way your body breaks down certain anesthetic drugs:

  • Cytochrome P450 enzyme induction
    Long-term exposure to THC and other cannabinoids stimulates liver enzymes (particularly CYP1A2 and CYP3A4). These enzymes metabolize common anesthetic agents such as midazolam, fentanyl, and propofol. Faster metabolism often means you require higher doses to achieve the same effect.

  • Altered plasma protein binding
    Cannabis components can change levels of albumin and alpha-1-acid glycoprotein in the blood, affecting how much anesthetic remains free (active) versus bound (inactive).

2. Pharmacodynamic Interactions

Cannabis also influences how your nervous and cardiovascular systems respond to anesthesia:

  • Sympathetic nervous system activation
    THC can increase heart rate and blood pressure before anesthesia. During induction, this baseline sympathetic tone may blunt the usual blood pressure drop, requiring adjustments in vasopressors or deeper anesthetic depth.

  • Cross-tolerance with sedatives?
    Unlike alcohol or benzodiazepines, tobacco and cannabis don’t share the exact receptor pathways of GABA-based anesthetics. However, some studies suggest a degree of tolerance to sedative effects, meaning more propofol or volatile agents may be needed for the same sedative response.

3. Clinical Evidence on Dose Requirements

Several peer-reviewed studies have noted increased anesthetic requirements in regular cannabis users:

  • A 2013 observational study found that chronic cannabis users required up to 30% more propofol for the same depth of sedation during outpatient procedures.
  • Research published in the Journal of Clinical Anesthesia (2020) reported higher fentanyl consumption intraoperatively among daily cannabis users compared with non-users.
  • Volatile anesthetics (e.g., sevoflurane) may also need to be administered at slightly higher Minimum Alveolar Concentrations (MAC) in habitual users to prevent movement in response to surgical stimuli.

4. Implications for “Medical Cannabis Before Anesthesia”

If you take cannabis therapeutically for pain, nausea, or other conditions, discussing it as part of your pre-operative assessment is vital:

  • Accurate history taking
    Let your anesthesiologist know the form (smoke, oil, edible), dose, frequency, and timing of your last use.

  • Adjusting induction and maintenance doses
    Your care team may plan for:

    • A higher starting dose of intravenous induction agents (e.g., propofol, etomidate)
    • Increased opioid dosing (e.g., fentanyl, remifentanil) for analgesia
    • Slightly higher end-tidal concentrations of volatile anesthetics
  • Monitoring hemodynamics
    Expect close blood pressure and heart rate monitoring. Additional vasoactive medications may be on standby.

5. Balancing Risks and Benefits

While dose increases are often modest (10–30%), unrecognized cannabis use can lead to:

  • Inadequate anesthesia
    Resulting in awareness under anesthesia, patient movement, or intraoperative hypertension.

  • Over-sedation concern
    If providers increase doses without understanding your tolerance, there’s a risk of prolonged recovery or respiratory depression.

6. Pre-operative Recommendations

To optimize your safety when using medical cannabis before anesthesia:

  1. Disclose use early
    Mention cannabis during your first pre-op visit, not on the day of surgery.

  2. Time your last dose
    Some providers recommend stopping inhaled cannabis 24–48 hours before surgery and oral forms 72 hours prior. This window allows enzyme activity and cannabinoid levels to decrease.

  3. Hydration and nutrition
    Cannabis can affect appetite and hydration. Arriving well-hydrated and nourished supports smoother anesthesia and recovery.

  4. Avoid mixing substances
    Combining cannabis with alcohol or other sedatives can amplify effects unpredictably.

  5. Discuss alternative therapies
    If you use cannabis for anxiety or chronic pain, inquire about non-cannabis options in the perioperative period.

7. Post-operative Considerations

  • Pain management
    Habitual users may require higher opioid doses post-op. Multimodal analgesia (acetaminophen, NSAIDs, regional blocks) can reduce total opioid needs.

  • Monitoring for withdrawal
    Abrupt cannabis cessation can cause irritability, insomnia, or nausea. Let your team know if you develop these symptoms so they can offer supportive care.

  • Resuming medical cannabis
    Discuss timing for restarting your usual dose, balancing pain control with safe recovery.

8. Practical Takeaway

Understanding how medical cannabis before anesthesia influences dosing helps you and your care team:

  • Optimize anesthetic depth
  • Minimize complications like under- or over-sedation
  • Improve overall perioperative experience

If you’re unsure how cannabis interacts with your planned anesthetic, you can consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker to gather information on your symptoms and flag any concerns before speaking to your provider.

9. When to Speak to a Doctor

If you experience any of the following, contact a healthcare professional immediately:

  • Uncontrolled heart rate or blood pressure
  • Severe respiratory issues
  • Chest pain or arrhythmias
  • Signs of severe withdrawal (e.g., confusion, hallucinations)

Always speak to a doctor about medical cannabis use and anesthesia planning. Your safety depends on thorough communication and personalized dosing strategies.

(References)

  • * Winek CL. Some historical aspects of marijuana. Clin Toxicol. 1977;10(2):243-53. doi: 10.3109/15563657708987969. PMID: 322936.

  • * Collier BB. Ketamine and the conscious mind. Anaesthesia. 1972 Apr;27(2):120-34. doi: 10.1111/j.1365-2044.1972.tb08186.x. PMID: 5021517.

  • * Dyment PG. Drug misuse by adolescent athletes. Pediatr Clin North Am. 1982 Dec;29(6):1363-8. doi: 10.1016/s0031-3955(16)34286-9. PMID: 6129607.

  • * Westerman ST, Golz A, Komorowski FS, Gilbert LM. Qualitative measurement of drugs. Laryngoscope. 1984 Feb;94(2 Pt 1):165-70. doi: 10.1288/00005537-198402000-00002. PMID: 6694484.

  • * Yevenes GE, Zeilhofer HU. Allosteric modulation of glycine receptors. Br J Pharmacol. 2011 Sep;164(2):224-36. doi: 10.1111/j.1476-5381.2011.01471.x. PMID: 21557733; PMCID: PMC3174402.

  • * van Amsterdam J, Nabben T, van den Brink W. Recreational nitrous oxide use: Prevalence and risks. Regul Toxicol Pharmacol. 2015 Dec;73(3):790-6. doi: 10.1016/j.yrtph.2015.10.017. Epub 2015 Oct 22. PMID: 26496821.

  • * Derman W. "Deromanticising" the Image of Pain in Athletes. Clin J Sport Med. 2018 Sep;28(5):415-416. doi: 10.1097/JSM.0000000000000655. PMID: 30153173.

  • * Machado KDC, Islam MT, Ali ES, Rouf R, Uddin SJ, Dev S, Shilpi JA, Shill MC, Reza HM, Das AK, Shaw S, Mubarak MS, Mishra SK, Melo-Cavalcante AAC. A systematic review on the neuroprotective perspectives of beta-caryophyllene. Phytother Res. 2018 Dec;32(12):2376-2388. doi: 10.1002/ptr.6199. Epub 2018 Oct 3. PMID: 30281175.

  • * Wiffen P. The cannabis conundrum. Eur J Hosp Pharm. 2020 Jan;27(1):1. doi: 10.1136/ejhpharm-2019-002154. Epub 2019 Nov 26. PMID: 32064080; PMCID: PMC6992964.

  • * Wu J, Hua L, Liu W, Yang X, Tang X, Yuan S, Zhou S, Ye Q, Cui S, Wu Z, Lai L, Tang C, Wang L, Yi W, Yao L, Xu N. Electroacupuncture Exerts Analgesic Effects by Restoring Hyperactivity via Cannabinoid Type 1 Receptors in the Anterior Cingulate Cortex in Chronic Inflammatory Pain. Mol Neurobiol. 2024 May;61(5):2949-2963. doi: 10.1007/s12035-023-03760-7. Epub 2023 Nov 13. PMID: 37957422; PMCID: PMC11043129.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.